Table 5b: Correlation analysis (2).

Disadvantage Side effects Other drug Non compl How many Pyramid Sensit cerebel brainstem visual sphincter Other Knowl MS Physic Tv, internet Patients other > awaren > worries New ther
Age
Gender
Distance
Primary school
High school
Graduate
Married
Income 2
Income 3
Avonex
Rebif
Betaf/ext
Copaxone
Years dis
Relapses
> Severe
= Severe
< Severe
+ 5 years
Years of therapy
1 Disadvantages
0.333* 1 Side effects
0.098 0.293* 1 Other drug
0.447 0.149 -0.073 1 Non compl
0.365* 0.122 -0.178 0.816* 1 How many
0.135 0.135 0.197* 0.100 0.000 1 Pyramid
0.172 0.024 0.275* -0.163 -0.044 0.810* 1 Sensit
0.480* 0.222* -0.154 0.340* 0.406* 0.560* 0.434* 1 Cerebel
-0.118 0.118 0.312* -0.476* -0.346* 0.654* 0.792* 0.303* 1 Brainstem
-0.182 0.230* 0.596* -0.298* -0.331* 0.677* 0.521* 0.151 0.623* 1 Visual
0.029 0.243* 0.223* 0.065 0.231* 0.611* 0.655* 0.337* 0.508* 0.490* 1 Sphinct
-0.152 0.096 0.007 0.154 0.428 0.065 0.086 0.181 0.142 0.148 0.550* 1 Other
-0.293* -0.098 0.048 -0.218* 0.000 0.066 0.036 -0.086 0.312* 0.195* 0.0143 0.141 1 Knowl MS
-0.163 -0.228* 0.237* -0.073 -0.178 -0.153 -0.108 -0.246* 0.035 -0.065 -0.385* 0.007 0.429* 1 Physicians
-0.149 -0.149 -0.218* 0.000 0.136 -0.201* -0.274* 0.078 -0.053 -0.244* -0.239* 0.216* 0.655* 0.364* 1 Tv, internet
0.200* 0.067 0.228* -0.149 -0.122 0.404* 0.368* 0.152 0.450* 0.545* 0.224* -0.096 0.098 -0.293* -0.447* 1 Patients
0.200* 0.067 -0.293* -0.149 -0.122 0.225* 0.368 0.339* 0.450* -0.230* 0.068 -0.096 0.098 0.228* 0.149 -0.067 1 Other
-0.230* 0.664* 0.000 0.139 0.153 -0.040 -0.252* -0.156 -0.208* 0.165 0.136 0.322* 0.000 -0.119 -0.000 -0.221* -0.221 1 > Aware
0.067 0.200* 0.163 0.149 0.243* 0.584* 0.417* 0.269* 0.308* 0.569* 0.672* 0.482* 0.293* -0.098 0.149 0.333* -0.200* 0.230* 1 > Worrie
0.683* 0.228* -0.238* 0.364* 0.416* 0.329* 0.203* 0.794* 0.058 -0.029 0.157 -0.007 -0.048 -0.238* -0.073 0.293* 0.293* -0.230 0.358* 1 New ther

* = significant at 95%